Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pre-Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01843829
What this trial is testing

A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer

Who this might be right for
Oesophageal Cancer
Lisette Nixon 85
Testing effectiveness (Phase 2)Temporarily pausedNCT04855253
What this trial is testing

Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL

Who this might be right for
DLBCLDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more
Masonic Cancer Center, University of Minnesota 30
Not applicableStudy completedNCT01535729
What this trial is testing

An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 465
Not applicableLooking for participantsNCT06550687
What this trial is testing

Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

Who this might be right for
All Types of Metastatic Solid Malignancy1st-line TreatmentExome Analysis+1 more
Centre Georges Francois Leclerc 80
Large-scale testing (Phase 3)Study completedNCT06058793
What this trial is testing

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Who this might be right for
Liposarcoma, Dedifferentiated
Boehringer Ingelheim 138
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Not applicableStudy completedNCT01542021
What this trial is testing

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate CancerProstatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT05336721
What this trial is testing

A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC

Who this might be right for
Triple-negative Breast Cancer
Chipscreen Biosciences, Ltd. 9
Not applicableStudy completedNCT06429163
What this trial is testing

Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy

Who this might be right for
Fibroid UterusPain, Postoperative
Saint Petersburg State University, Russia 207
Early research (Phase 1)Study completedNCT00403221
What this trial is testing

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Baylor College of Medicine 19
Large-scale testing (Phase 3)Study completedNCT03879109
What this trial is testing

Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital, Bordeaux 58
Early research (Phase 1)Ended earlyNCT02112162
What this trial is testing

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Who this might be right for
Rectal Neoplasms
Washington University School of Medicine 2
Early research (Phase 1)Ended earlyNCT01975688
What this trial is testing

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Who this might be right for
Head and Neck Squamous Cell Carcinoma
GW Pharmaceuticals Ltd 10
Not applicableUnknownNCT04116827
What this trial is testing

Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

Who this might be right for
Sleep DisorderBreast Cancer
Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT02830061
What this trial is testing

The Experience of TYAC Offered Ovarian Tissue Cryopreservation

Who this might be right for
CancerFertility
University of Oxford 12
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Very early researchLooking for participantsNCT05800405
What this trial is testing

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center 9
Large-scale testing (Phase 3)Looking for participantsNCT07518186
What this trial is testing

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 700
Testing effectiveness (Phase 2)Study completedNCT00229203
What this trial is testing

Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
PharmaMar 51
Next Page